tiprankstipranks
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market

Enliven Therapeutics (ELVN) Technical Analysis

267 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Enliven Therapeutics’s (ELVN) Moving Averages Convergence Divergence (MACD) indicator is 0.40, suggesting Enliven Therapeutics is a Buy.
Enliven Therapeutics’s (ELVN) 20-Day exponential moving average is 22.95, while Enliven Therapeutics’s (ELVN) share price is $22.01, making it a Sell.
Enliven Therapeutics’s (ELVN) 50-Day exponential moving average is 22.06, while Enliven Therapeutics’s (ELVN) share price is $22.01, making it a Sell.

Enliven Therapeutics (ELVN) Pivot Points

Jul 22, 2024, 11:11 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.39
20.83
21.71
23.15
24.04
25.47
26.36
Fibonacci
20.83
21.71
22.26
23.15
24.04
24.58
25.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enliven Therapeutics (ELVN) Moving Averages

Jul 22, 2024, 11:11 AM
Period
Simple
Exponential
MA5
23.62Sell
23.08Sell
MA10
23.54Sell
23.23Sell
MA20
22.83Sell
22.95Sell
MA50
22.63Sell
22.06Sell
MA100
20.15Buy
20.51Buy
MA200
16.71Buy
18.09Buy
Enliven Therapeutics’s (ELVN) 10-Day exponential moving average is 23.23, while Enliven Therapeutics’s (ELVN) share price is $22.01, making it a Sell.
Enliven Therapeutics’s (ELVN) 100-Day exponential moving average is 20.51, while Enliven Therapeutics’s (ELVN) share price is $22.01, making it a Buy.
Enliven Therapeutics’s (ELVN) stock price is $22.01 and Enliven Therapeutics’s (ELVN) 50-day simple moving average is 22.63, creating a Sell signal.
Enliven Therapeutics’s (ELVN) stock price is $22.01 and Enliven Therapeutics’s (ELVN) 100-day simple moving average is 20.15, creating a Buy signal.
Enliven Therapeutics’s (ELVN) stock price is $22.01 and Enliven Therapeutics’s (ELVN) 200-day simple moving average is 16.71, creating a Buy signal.

Enliven Therapeutics (ELVN) Technical Indicators

Jul 22, 2024, 11:11 AM
Name
Value
Implied Action
RSI (14)
45.63
Neutral
STOCH (9,6)
24.07
Neutral
STOCHRSI (14)
43.90
Neutral
MACD (12,26)
0.40
Buy
ADX (14)
12.96
Buy
Williams %R
-71.95
Buy
CCI (14)
-40.86
Neutral
ATR (14)
1.41
-
Ultimate Oscillator
43.23
Neutral
ROC
-5.82
Sell
Enliven Therapeutics’s (ELVN) Relative Strength Index (RSI) is 45.63, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Trend Strength Indicator (ADX) is 12.96, creating a Buy signal.
Enliven Therapeutics’s (ELVN) Commodity Channel Index (CCI) is -40.86, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Price Rate of Change (ROC) is -5.82, creating a Sell signal.

FAQ

Is ELVN a Buy, Hold, or Sell?
Based on ELVN’s technical indicators, ELVN is a Sell.
    What is ELVN’s RSI (14)?
    ELVN’s RSI (14) is 45.63, which suggests ELVN is a Neutral.
      What is ELVN’s MACD?
      ELVN’s MACD is 0.40, which suggests ELVN is a Buy.
        What is ELVN’s 5-day moving average?
        ELVN’s 5-day moving average is 23.62, which suggests ELVN is a Sell.
          What is ELVN’s 20-day moving average?
          ELVN 20-day moving average is 22.83, which suggests ELVN is a Sell.
            What is ELVN’s 50-day moving average?
            ELVN’s 50-day moving average is 22.63, which suggests ELVN is a Sell.
              What is ELVN’s 200-day moving average?
              ELVN’s 200-day moving average is 16.71, which suggests ELVN is a Buy.
                What is ELVN’s Williams % R (14)?
                ELVN’s Williams % R (14) is -71.95, which suggests ELVN is a Buy.
                  What is ELVN’s CCI (14)?
                  ELVN’s CCI (14) is -40.86, which suggests ELVN is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis